If successful, the benefits of real-time biomarker monitoring could constitute a revolution in modern medicine - Alex Berezow
image by: Israel in the Philippines
The annual physical exam is under fire. Increasingly, physicians believe that the yearly ritual of having our bodies poked and prodded is completely useless, save for the fraction of patients who have a chronic illness or predisposition to disease. Worse, the annual physical is estimated to cost our healthcare system approximately $8 billion for arguably little benefit.
It is unlikely, however, that check-ups will go away completely. Despite the growing consensus against them among medical professionals, 92 percent of Americans believe that the exams are still important. Perhaps that shouldn’t be a surprise. Health anxiety has become something of a national pastime for many of us.
Modern technology could do a better job of picking up health problems before they get out of hand.
BiomarkerBay is a service concept that brings together academic expertise and contract research organizations to provide integrated services for the validation, bioanalysis and clinical testing of novel biomarkers and companion diagnostics.
The journal Biomarkers brings together all aspects of the rapidly growing field of biomarker research, encompassing their various uses and applications in one essential source. Biomarkers provides a vital forum for the exchange of ideas and concepts in all areas of biomarker research.
In addition to the full conference agenda, this event offers you the chance to meet face-to-face with leading industry solution providers and senior-level industry peers through a series of formal and informal networking opportunities.
The Biomarkers Consortium is a major public-private biomedical research partnership managed by the Foundation for the National Institutes of Health (FNIH) with broad participation from stakeholders across the health field, including government, industry, academia and patient advocacy and other not-for-profit organizations.
Biomarkers in Medicine (ISSN: 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.
Journal of Biomarkers is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies in all areas of biomarkers.
Journal of Molecular Biomarkers and Diagnosis is a broad-based journal found on two key tenets: To publish the most exciting Reviews on Molecular Biomarkers and diagnosis: Second to provide a rapid turn-around time possible for reviewing and publishing of articles freely for research, teaching and reference purposes.
Finding new preclinical biomarkers for research or clinical biomarkers for personalized treatments and companion diagnostics.
Learn about biomarkers, colorectal cancer biomarker testing, how biomarkers impact cancer treatment, and why you need to know your biomarker.
Your Path to Meaningful Connections in the World of Health and Medicine
Connect, Collaborate, and Engage!
Coming Soon - Stitches, the innovative chat app from the creators of HWN. Join meaningful conversations on health and medical topics. Share text, images, and videos seamlessly. Connect directly within HWN's topic pages and articles.